Financial Summary (All financials)
| In millions, except per share items | Jul-31-17 | Jul-31-16 | Jul-31-15 | Jul-31-14 | Jul-31-13 | Jul-31-12 |
| Revenues | 0.7 | 2.2 | 13.2 | 4.8 | 1.1 | 0.6 |
| Revenue growth | -69.5% | -83.7% | 176.1% | 324.4% | 104.3% | |
| Cost of goods sold | 0.1 | 0.9 | 6.0 | 2.5 | 0.6 | 0.1 |
| Gross profit | 0.5 | 1.2 | 7.2 | 2.3 | 0.5 | 0.5 |
| Gross margin | 82.5% | 56.7% | 54.4% | 48.1% | 44.2% | 83.4% |
| Selling, general and administrative | 20.8 | 9.0 | 6.9 | 3.0 | 3.1 | 1.0 |
| Research and development | 0.6 | 1.3 | | | | |
| EBIT | -35.8 | -9.1 | 0.3 | -0.7 | -4.6 | 10.1 |
| EBIT margin | -5442.4% | -421.5% | 2.0% | -14.4% | -408.4% | 1828.4% |
| Pre-tax income | -45.6 | -8.7 | 0.6 | -0.3 | -3.6 | 4.8 |
| Income taxes | 0.0 | 0.0 | 2.7 | -2.4 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 425.4% | 828.5% | | 0.5% |
| Net income | -44.6 | -8.3 | -2.0 | 2.0 | -3.2 | 4.8 |
| Net margin | -6785.3% | -384.8% | -14.8% | 42.5% | -284.3% | 866.0% |
| |
| Diluted EPS | ($3.67) | ($0.70) | ($0.17) | $0.18 | ($0.31) | $0.39 |
| Shares outstanding (diluted) | 12.2 | 11.9 | 11.5 | 11.3 | 10.5 | 12.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|